THERAPY FOR HEPATOCELLULAR CANCER WITH INTRA-HEPATIC ARTERIAL ADRIAMYCIN AND 5-FLUOROURACIL COMBINED WITH WHOLE-LIVER IRRADIATION - NORTHERN CALIFORNIA ONCOLOGY GROUP-STUDY
- 1 January 1979
- journal article
- research article
- Vol. 63 (11-1) , 1885-1888
Abstract
Patients (13) with hepatocellular cancer were treated with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation. Six patients (46%) had an objective regression and 5 (38%) had stable disease. Symptomatic improvement was noted in 81% of the patients. The minimum median survival time was 5.0 mo. for those patients who responded. Toxicity was acceptable. This is an effective combination for the treatment of this especially aggressive and intractable form of cancer.This publication has 6 references indexed in Scilit:
- Chemotherapy studies in primary liver cancer. A prospective randomized clinical trialCancer, 1978
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinomaCancer, 1977
- A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United StatesCancer, 1977
- Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinomaCancer, 1977
- Cellular effects of combined adriamycin and x‐irradiation in human tumor cellsInternational Journal of Cancer, 1977